Hemangioma: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 2: | Line 2: | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{Hemangioma}} | {{Hemangioma}} | ||
{{CMG}}; {{AE}}{{JH}} {{NM}} | {{CMG}}; {{AE}}{{JH}} {{NM}}{{ADS}} | ||
{{SK}} Haemangioma | {{SK}} Haemangioma | ||
| Line 34: | Line 34: | ||
==Case Studies== | ==Case Studies== | ||
[[Hemangioma case study one|Case #1]] | [[Hemangioma case study one|Case #1]] | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 39: | Line 42: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Vascular medicine]] | [[Category:Vascular medicine]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Latest revision as of 22:00, 29 July 2020
For patient information click here
|
Hemangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemangioma On the Web |
|
American Roentgen Ray Society Images of Hemangioma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2] Nawal Muazam M.D.[3]Amandeep Singh M.D.[4]
Synonyms and keywords: Haemangioma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies